Kaibo Guo

681 total citations
44 papers, 431 citations indexed

About

Kaibo Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kaibo Guo has authored 44 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Kaibo Guo's work include Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Cells and Metastasis (6 papers). Kaibo Guo is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Gastric Cancer Management and Outcomes (7 papers) and Cancer Cells and Metastasis (6 papers). Kaibo Guo collaborates with scholars based in China, United Kingdom and United States. Kaibo Guo's co-authors include Shanming Ruan, Yuqian Feng, Leitao Sun, Minhe Shen, Harpreet Wasan, Huimin Jin, Kai Zhang, Yuan Li, Ying Zhu and Shengyou Lin and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Medicine.

In The Last Decade

Kaibo Guo

41 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaibo Guo China 13 175 141 121 91 82 44 431
Ke Cheng China 12 151 0.9× 133 0.9× 79 0.7× 84 0.9× 68 0.8× 43 398
Chun‐Chieh Wu Taiwan 12 200 1.1× 187 1.3× 171 1.4× 77 0.8× 87 1.1× 32 466
Nanzheng Chen China 13 139 0.8× 191 1.4× 139 1.1× 202 2.2× 99 1.2× 29 495
Jun Qian China 14 185 1.1× 110 0.8× 107 0.9× 90 1.0× 79 1.0× 39 508
Jianzhuang Ren China 12 82 0.5× 180 1.3× 88 0.7× 47 0.5× 102 1.2× 26 401
Xuan Zhu China 12 157 0.9× 173 1.2× 141 1.2× 66 0.7× 129 1.6× 38 433
Hikota Hayashi Japan 11 171 1.0× 76 0.5× 126 1.0× 164 1.8× 83 1.0× 25 421
Xixu Zhu China 13 114 0.7× 192 1.4× 233 1.9× 59 0.6× 92 1.1× 31 544

Countries citing papers authored by Kaibo Guo

Since Specialization
Citations

This map shows the geographic impact of Kaibo Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaibo Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaibo Guo more than expected).

Fields of papers citing papers by Kaibo Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaibo Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaibo Guo. The network helps show where Kaibo Guo may publish in the future.

Co-authorship network of co-authors of Kaibo Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Kaibo Guo. A scholar is included among the top collaborators of Kaibo Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaibo Guo. Kaibo Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yijing, et al.. (2024). Emerging biomarkers for immunotherapy response in biliary tract cancers: a comprehensive review of immune checkpoint inhibitor strategies. Biomarkers in Medicine. 18(15-16). 703–715. 2 indexed citations
2.
Chen, Wenqian, et al.. (2024). Hedgehog pathway and cancer: A new area (Review). Oncology Reports. 52(3). 4 indexed citations
4.
Lu, Jiamin, Yuqian Feng, Kaibo Guo, Leitao Sun, & Kai Zhang. (2024). Association between inflammatory factors and melanoma: a bidirectional Mendelian randomization study. Cancer Causes & Control. 35(10). 1333–1342.
5.
Lu, Jiamin, Yuqian Feng, Kaibo Guo, et al.. (2024). Prognostic value of preoperative circulating tumor DNA in non-small cell lung cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 150(1). 25–25. 4 indexed citations
6.
Guo, Kaibo, et al.. (2023). Prognostic value of postoperative ctDNA detection in patients with early non-small cell lung cancer: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology. 15. 2621744–2621744. 4 indexed citations
7.
Guo, Kaibo, et al.. (2023). Predictors of Distant Metastasis and Prognosis in Newly Diagnosed T1 Intrahepatic Cholangiocarcinoma. BioMed Research International. 2023(1). 6638755–6638755. 1 indexed citations
8.
Guo, Kaibo, et al.. (2023). Case Report: Pancreatic metastasis of renal cell carcinoma 16 years after nephrectomy. Frontiers in Oncology. 13. 1091635–1091635. 1 indexed citations
9.
Feng, Yuqian, Kaibo Guo, Jing Jiang, & Shengyou Lin. (2023). Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases. Biomedicine & Pharmacotherapy. 170. 116008–116008. 19 indexed citations
10.
Yang, Jingjing, et al.. (2023). Survival analysis of age-related oral squamous cell carcinoma: a population study based on SEER. European journal of medical research. 28(1). 413–413. 9 indexed citations
12.
Li, Yuan, Shaowei Mo, Zhiyuan Xu, et al.. (2021). p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier. Pharmacological Research. 165. 105411–105411. 16 indexed citations
13.
Feng, Yuqian, et al.. (2021). Causes of Death After Colorectal Cancer Diagnosis: A Population-Based Study. Frontiers in Oncology. 11. 647179–647179. 23 indexed citations
14.
Guo, Kaibo, Yuqian Feng, Leitao Sun, et al.. (2021). Resveratrol and Its Analogs: Potent Agents to Reverse Epithelial-to-Mesenchymal Transition in Tumors. Frontiers in Oncology. 11. 644134–644134. 25 indexed citations
15.
Guo, Kaibo, et al.. (2021). The prognostic value of 4.1 mRNA expression in non-small cell lung cancer. Translational Cancer Research. 10(3). 1216–1228. 2 indexed citations
16.
Jin, Huimin, et al.. (2021). Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?. Frontiers in Pharmacology. 12. 572845–572845. 7 indexed citations
17.
Jin, Huimin, Yuqian Feng, Kaibo Guo, & Shanming Ruan. (2020). Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Early Onset Colon Adenocarcinoma. Frontiers in Oncology. 10. 595354–595354. 5 indexed citations
18.
Wang, Peipei, Shuning Ding, Leitao Sun, et al.. (2020). Characteristics and differences of gut microbiota in patients with different Traditional Chinese Medicine Syndromes of Colorectal Cancer and normal population. Journal of Cancer. 11(24). 7357–7367. 22 indexed citations
19.
Zhang, Kai, Leitao Sun, Yuan Li, et al.. (2018). Jiedu Sangen Decoction Inhibits Migration and Invasion of Colon Cancer SW480 Cells via Suppressing Epithelial Mesenchymal Transition. Evidence-based Complementary and Alternative Medicine. 2018(1). 1495768–1495768. 9 indexed citations
20.
Guo, Kaibo, et al.. (2018). Association between the overexpression of Her3 and clinical pathology and prognosis of colorectal cancer. Medicine. 97(37). e12317–e12317. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026